Curisium

Curisium is the American startup developing the blockchain technology of the same name for health care. Development of the company allows to automate payments and transfer of medical data between clinics, insurance companies and patients.

The transparency of all stages of the transaction and compact structure which simplifies contracts and allows to draw new conclusions from incomplete data carry the high level of cryptographic protection (it guarantees that data are used only within the contract), to advantages of the blockchain platform in Curisium.

2017: Investment attraction

In December, 2017 Curisium attracted $3.5 million investments. Flare Capital Partners, New Enterprise Associates (NEA), Shuttle Fund, Sanofi Ventures and Green Bay Ventures invested in the company.

Will aim Curisium received from investors of means at the development of the medical blockchain platform.

In the released Curisium in December, 2017 the press release it is said that nearly a third of the payments made in the American market of health care of $2.7 trillion of dollars is the share of alternative models of payment. It provides the huge potential of technology of the company.

The blockchain project on automation of payments in health care of Curisium attracted $3.5 million investments

Payers, suppliers of medical services and the medical companies even more often enter different forms of the innovation contracts. However their effective implementation is complicated by expensive logistics, mistrust and difficulty of check of results at the level of patients today — the cofounder and the CEO of Curisium Peter Kim noted.

According to the co-founder of Flare Capital company Bill Geary, the technology offered Curisium which provides individual check of transactions in the future can become a basis for the innovation interaction of participants of the market of health care.^[1]

Notes